Treatment of Sleep-disordered Breathing in Patients With SCI
CompletedNAResults postedLast updated 19 May 2021
What this trial tests
NA trial testing Best practices PAP + patient Education +ongoing Support and Training in Spinal Cord Injury in 73 participants. Completed in 30 March 2020.
18 and older, any sex, with Spinal Cord Injury or Sleep-disordered Breathing. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
PAP AdherencePrimary· 90 days
Number of nights positive airway pressure (PAP) was used \>=4 hours during the first 90 days measured by remote monitoring. Scores range from 0 to 90 days. Higher scores indicate better outcome.
Group
Value
95% CI
The BEST Program
22.03
± 24.74
Sleep Education and Standard Sleep-disordered Breathing Treatment
18.54
± 24.67
Subjective Sleep Quality Was Measured by The Pittsburgh Sleep Quality Index (PSQI)Primary· 90 days
The Pittsburgh Sleep Quality Index (PSQI) is an 18-item questionnaire that assesses sleep quality and disturbances over the past month. The PSQI is sensitive for distinguishing normal and abnormal sleepers and has good test-retest reliability. The investigators will use the 3-factor scoring, which has been shown to have superior psychometric properties. This will be used as the main independent measure of sleep quality.
The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality
Group
Value
95% CI
The BEST Program
6.96
± 4.12
Sleep Education and Standard Sleep-disordered Breathing Treatment
9.1
± 4.97
Quality of Life Was Measured by WHO-QOL BREF QuestionnaireSecondary· 90 days
The questionnaire is composed of four domains: physical health, psychological health, social relationships and environment. It also includes one question on overall quality of life and one on general health. Importantly, items on this scale are not dependent on mobility, which is unlikely to change in patients with Spinal Cord Injury/Disease as a result of improved sleep. The WHOQOL-BREF scores correlate highly (.89 or above) with WHOQOL-100 scores, and demonstrate good discriminant validity, content validity, internal consistency and test-retest reliability. The four WHOQOL-BREF domain scores
WHO-QOL phys
Group
Value
95% CI
The BEST Program
60.13
± 21.37
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
54.72
± 22.08
WHO-QOL psych
Group
Value
95% CI
The BEST Program
69.22
± 14.69
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
62.90
± 19.64
WHO-QOL Soc
Group
Value
95% CI
The BEST Program
63.70
± 24.39
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
57.52
± 23.20
WHO-QOL ENV
Group
Value
95% CI
The BEST Program
74.09
± 12.66
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
69.75
± 18.40
Respiratory Function: Spirometry and Respiratory Muscle ForceSecondary· 90 days
Spirometry is a simple bedside test used to evaluate lung function. Key spirometry values include forced vital capacity (FVC) and forced expiratory volume over 1 second (FEV1) and the absolute FEV1/FVC ratio. If the FVC and FEV1 are decreased, the absolute FEV1/FVC ratio distinguishes between obstructive and restrictive impairments. A normal absolute FEV1/FVC ratio suggest that restrictive ventilatory impairment may be present, and a reduced FEV1 and absolute FEV1/FVC ratio indicates an obstructive ventilator pattern. The investigators will use supine FVC and maximal inspiratory pressure (MIP)
Group
Value
95% CI
The BEST Program
3.38
± 1.04
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
3.20
± 0.97
Functional Status Was Measured by CHART Questionnaire.Secondary· 90 days
The CHART is a measure of overall function. The scale is divided into five separate domain scores: Physical, Cognitive, Mobility, Occupation, and Social integration.
Each of the five domains scored from 0-100. higher number indicates better outcome.
Physical
Group
Value
95% CI
The BEST Program
79.09
± 31.02
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
82.70
± 31.39
Cognitive
Group
Value
95% CI
The BEST Program
70.70
± 23.90
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
78.83
± 22.44
Mobility
Group
Value
95% CI
The BEST Program
82.20
± 19.64
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
78.17
± 24.33
Occupation
Group
Value
95% CI
The BEST Program
48.98
± 31.39
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
38.90
± 33.76
Social integration
Group
Value
95% CI
The BEST Program
79
± 23.64
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
66.80
± 29.42
Depressive Symptom SeveritySecondary· 90 days
The Patient Health Questionnaire-9 (PHQ-9) is a 9-item depression module in the PHQ (a self-administered diagnostic instrument for common mental disorders) which is part of the Primary Care Evaluation of Mental Disorders (PRIME-MD) suite of evaluation tools. The PHQ-9 aligns to the DSM-IV diagnostic criteria for depression and is widely used to screen for depression across VA. The PHQ-9 total score will be used to measure depressive symptom severity as an outcome.
As a severity measure, the PHQ-9 score can range from 0 to 27. Higher the value, worse the outcome.
Group
Value
95% CI
The BEST Program
5.03
± 5.89
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
8.38
± 6.44
Fatigue SymptomsSecondary· 90 days
The Flinders Fatigue Scale (FFS) is a 7-item fatigue rating scale used to measure general symptoms of fatigue. The FFS total score will be used as an outcome measure.
Total fatigue scores range from 0 to 31, with higher scores indicating greater fatigue.
Group
Value
95% CI
The BEST Program
9.61
± 8.46
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
12.12
± 9.33
Epworth Sleepiness ScaleSecondary· 90 days
The Epworth Sleepiness Scale (ESS) is a self-administered questionnaire that quantifies daytime sleepiness, with higher scores indicating increased daytime hypersomnolence The ESS is ranging from 0 to 24. higher scores indicate more sleepiness
Group
Value
95% CI
The BEST Program
4.58
± 4.94
Sleep Education and Standard Sleep-disordered Breathing (SDB) Treatment
6.48
± 4.13
Sponsor's own description
Sleep-disordered breathing (SDB) remains under-treated in individuals living with spinal cord injuries and disorders (SCI/D). The investigators' aim is to test a program that addresses challenges and barriers to positive airway pressure (PAP) treatment of SDB among patients with SCI/D. The investigators anticipate that patients who receive this program will have higher rates of PAP use and will demonstrate improvements in sleep quality, general functioning, respiratory functioning and quality of life from baseline to 6 months follow up compared to individuals who receive a control program. This work addresses critical healthcare needs for patients with SCI/D and may lead to improved health and quality of life for these patients.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
NCT05926596 — Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
· NA
· recruiting
NCT06839300 — The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study
· recruiting
NCT07036107 — A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the S
· NA
· recruiting
Other VA Office of Research and Development trials
Trials by the same sponsor.
NCT07456150 — Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care
· Phase 1
· not yet recruiting
NCT06746727 — The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veteran
· NA
· not yet recruiting
NCT07362576 — Perinatal Peer Support for Veterans With Serious Mental Illness
· NA
· not yet recruiting
NCT06766331 — Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
· NA
· not yet recruiting
NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VA Office of Research and Development
Last refreshed: 19 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02830074.